206 related articles for article (PubMed ID: 28904956)
1. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
2. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
3. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
4. Genomics driven approach for identification of novel therapeutic targets in Salmonella enterica.
Gawade P; Ghosh P
Gene; 2018 Aug; 668():211-220. PubMed ID: 29778427
[TBL] [Abstract][Full Text] [Related]
5. Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in Europe.
Huehn S; La Ragione RM; Anjum M; Saunders M; Woodward MJ; Bunge C; Helmuth R; Hauser E; Guerra B; Beutlich J; Brisabois A; Peters T; Svensson L; Madajczak G; Litrup E; Imre A; Herrera-Leon S; Mevius D; Newell DG; Malorny B
Foodborne Pathog Dis; 2010 May; 7(5):523-35. PubMed ID: 20039795
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
9. Novel Drug Targets for Food-Borne Pathogen Campylobacter jejuni: An Integrated Subtractive Genomics and Comparative Metabolic Pathway Study.
Mehla K; Ramana J
OMICS; 2015 Jul; 19(7):393-406. PubMed ID: 26061459
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type beta-lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase genes [aac(6')-I30].
Mulvey MR; Boyd DA; Baker L; Mykytczuk O; Reis EM; Asensi MD; Rodrigues DP; Ng LK
J Antimicrob Chemother; 2004 Aug; 54(2):354-9. PubMed ID: 15231768
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
Batool N; Waqar M; Batool S
Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
[TBL] [Abstract][Full Text] [Related]
12. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
13. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica.
Gerlach RG; Hensel M
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):317-27. PubMed ID: 17715824
[TBL] [Abstract][Full Text] [Related]
14. Emergence of blaCTX-M-15, blaTEM-169 and blaPER-1 extended-spectrum β-lactamase genes among different Salmonella enterica serovars from human faecal samples.
Tajbakhsh M; Avini MY; Alikhajeh J; Tajeddin E; Rahbar M; Eslami P; Alebouyeh M; Zali MR
Infect Dis (Lond); 2016 Jul; 48(7):550-6. PubMed ID: 27117981
[TBL] [Abstract][Full Text] [Related]
15. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
16. Variant Salmonella genomic island 1 antibiotic resistance gene clusters in Salmonella enterica serovar Derby isolates from humans in Taiwan.
Chiu CH; Chen HL; Kao LS; Yang CY; Chu C; Doublet B; Praud K; Cloeckaert A
J Antimicrob Chemother; 2007 Feb; 59(2):325-6. PubMed ID: 17114174
[No Abstract] [Full Text] [Related]
17. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
[TBL] [Abstract][Full Text] [Related]
18. Variant Salmonella genomic island 1 antibiotic resistance gene cluster containing a novel 3'-N-aminoglycoside acetyltransferase gene cassette, aac(3)-Id, in Salmonella enterica serovar newport.
Doublet B; Weill FX; Fabre L; Chaslus-Dancla E; Cloeckaert A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3806-12. PubMed ID: 15388438
[TBL] [Abstract][Full Text] [Related]
19. Variant Salmonella genomic island 1-L antibiotic resistance gene cluster in Salmonella enterica serovar Newport.
Cloeckaert A; Praud K; Doublet B; Demartin M; Weill FX
Antimicrob Agents Chemother; 2006 Nov; 50(11):3944-6. PubMed ID: 16966396
[TBL] [Abstract][Full Text] [Related]
20. Subtractive genomics and molecular docking approach to identify drug targets against Stenotrophomonas maltophilia.
Saleem H; Ashfaq UA; Nadeem H; Zubair M; Siddique MH; Rasul I
PLoS One; 2021; 16(12):e0261111. PubMed ID: 34910751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
